Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17103
Country/Region: Tanzania
Year: 2016
Main Partner: Baylor College of Medicine
Main Partner Program: International Pediatric AIDS Initiative-Tanzania
Organizational Type: University
Funding Agency: USAID
Total Funding: $1,945,521 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $21,450
Treatment: Adult Treatment (HTXS) $383,432
Treatment: Pediatric Treatment (PDTX) $1,540,639
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 21
HTS_TST Age/sex: 1-9 2017 157
HTS_TST Age/sex: 10-14 Female 2017 5
HTS_TST Age/sex: 10-14 Male 2017 115
HTS_TST Age/sex: 15-19 Female 2017 16
HTS_TST Age/sex: 15-19 Male 2017 12
HTS_TST Age/sex: 20-24 Female 2017 18
HTS_TST Age/sex: 20-24 Male 2017 3
HTS_TST Age/sex: 25-49 Female 2017 73
HTS_TST Age/sex: 25-49 Male 2017 48
HTS_TST Age/sex: 50+ Female 2017 9
HTS_TST Age/sex: 50+ Male 2017 12
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 53
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 126
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 668
HTS_TST Service Delivery Point (Facility): Inpatient 2017 57
HTS_TST Service Delivery Point (Facility): Other PITC 2017 134
HTS_TST Service Delivery Point (Facility): Pediatric 2017 477
HTS_TST Sum of Age/Sex disaggregates 2017 311
HTS_TST Sum of Aggregated Age/Sex <15 2017 179
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 179
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 2
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 2
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 2
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 5
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 2
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 4
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 2
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 83
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 2
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 71
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 10
TB_SCREENDX Screen Result: Screened Positive for TB 2017 83
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,458
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,457
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 287
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 222
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 5,424
TX_CURR Age/Sex: <1 2017 8
TX_CURR Age/Sex: <1-9 2017 148
TX_CURR Age/Sex: 10-14 Female 2017 39
TX_CURR Age/Sex: 10-14 Male 2017 47
TX_CURR Age/Sex: 15-19 Female 2017 254
TX_CURR Age/Sex: 15-19 Male 2017 142
TX_CURR Age/Sex: 20-24 Female 2017 367
TX_CURR Age/Sex: 20-24 Male 2017 42
TX_CURR Age/Sex: 25-49 Female 2017 1,636
TX_CURR Age/Sex: 25-49 Male 2017 640
TX_CURR Age/Sex: 50+ Female 2017 201
TX_CURR Age/Sex: 50+ Male 2017 168
TX_CURR Aggregated Age/Sex: <15 Female 2017 72
TX_CURR Aggregated Age/Sex: <15 Male 2017 82
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,281
TX_CURR Aggregated Age/Sex: 15+ Male 2017 584
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 5,711
TX_CURR Sum of age/sex disaggregates 2017 396
TX_CURR Sum of Aggregated Age/Sex <15 2017 154
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,865
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,019
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 8
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 8
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 76
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 36
TX_NEW By Age/Sex: <1 2017 8
TX_NEW By Age/Sex: 1-9 2017 18
TX_NEW By Age/Sex: 10-14 Female 2017 3
TX_NEW By Age/Sex: 10-14 Male 2017 5
TX_NEW By Age/Sex: 15-19 Female 2017 56
TX_NEW By Age/Sex: 15-19 Male 2017 30
TX_NEW By Age/Sex: 20-24 Female 2017 63
TX_NEW By Age/Sex: 20-24 Male 2017 7
TX_NEW By Age/Sex: 25-49 Female 2017 253
TX_NEW By Age/Sex: 25-49 Male 2017 118
TX_NEW By Age/Sex: 50+ Female 2017 35
TX_NEW By Age/Sex: 50+ Male 2017 30
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 754
TX_NEW Sum of Age/Sex disaggregates 2017 600
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 128
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 2,421
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,182
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 77
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 75
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,416
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 614
TX_PVLS Numerator: Indication: Routine 2017 680
TX_PVLS Numerator: Indication: Targeted 2017 1,502
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 85
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 82
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,571
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 683
TX_PVLS_den Denominator: Indication: Routine 2017 754
TX_PVLS_den Denominator: Indication: Targeted 2017 1,667
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 25
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 28
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 114
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 53
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 78
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 37
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 412
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 551
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 33
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 38
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 153
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 71
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 21
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 104
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 49
Cross Cutting Budget Categories and Known Amounts Total: $569,852
Human Resources for Health $250,000
Food and Nutrition: Policy, Tools, and Service Delivery $148,578
Food and Nutrition: Commodities $29,837
Economic Strengthening $29,494
Education $99,676
Gender: Gender Based Violence (GBV) $12,267
GBV Prevention